CoChat

Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity

Open access

The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.

Abstract

Serotonin neurotransmitter deficits are reported in suicide, major depressive disorder (MDD) and alcohol use disorder (AUD). To compare pathophysiology in these disorders, we mapped brain serotonin transporter (SERT), 5-HT 1A, and 5-HT 2A receptor binding throughout prefrontal cortex and in anterior cingulate cortex postmortem. Cases and controls died suddenly minimizing agonal effects and had a postmortem interval ≤24 h to avoid compromised brain integrity. Neuropathology and toxicology confirmed absence of neuropathology and psychotropic medications. For most subjects (167 of 232), a DSM-IV Axis I diagnosis was made by psychological autopsy. Autoradiography was performed in right hemisphere coronal sections at a pre-genual level. Linear model analyses included sex and age with group and Brodmann area as interaction terms. SERT binding was lower in suicides (p = 0.004) independent of sex (females < males, p < 0.0001), however, the lower SERT binding was dependent on MDD diagnosis (p = 0.014). Higher SERT binding was associated with diagnosis of alcoholism (p = 0.012). 5-HT 1A binding was greater in suicides (p < 0.001), independent of MDD (p = 0.168). Alcoholism was associated with higher 5-HT 1A binding (p < 0.001) but only in suicides (p < 0.001). 5-HT 2A binding was greater in suicides (p < 0.001) only when including MDD (p = 0.117) and alcoholism (p = 0.148) in the model. Reported childhood adversity was associated with higher SERT and 5-HT 1A binding (p = 0.004) in nonsuicides and higher 5-HT 2A binding (p < 0.001). Low SERT and more 5-HT 1A and 5-HT 2A binding in the neocortex in depressed suicides is dependent on Axis I diagnosis and reported childhood adversity. Findings in alcoholism differed from those in depression and suicide indicating a distinct serotonin system pathophysiology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41398-018-0309-1

Cites

106 of 106 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Representative autoradiograms of receptor binding of [3H]-Cyanoimipramine to the serotonin transporter (left), [3H]-8-OH-DPAT to the 5-HT1A receptor (center) and [3H]-Ketanserin to the 5-HT2A receptor (right). The autoradiograms are from sections cut from the right hemisphere of a representative nonpsychiatric control. The upper row has images of total binding, the middle row is of nonspecific binding and the lower row has subtracted images of specific binding. See methods for displacers and assay conditions. The images were calibrated to fmol/mg tissue using radioactivity standards and color-mapped to a single scale on the right
Fig. 1 Representative autoradiograms of receptor binding of [3H]-Cyanoimipramine to the serotonin transporter (left), [3H]-8-OH-DPAT to the 5-HT1A receptor (center) and [3H]-Ketanserin to the 5-HT2A receptor (right). The autoradiograms are from sections cut from the right hemisphere of a representative nonpsychiatric control. The upper row has images of total binding, the middle row is of nonspecific binding and the lower row has subtracted images of specific binding. See methods for displacers and assay conditions. The images were calibrated to fmol/mg tissue using radioactivity standards and color-mapped to a single scale on the rightCC BY · PubMed Central
Fig. 2 Serotonin transporter (SERT) binding in the prefrontal cortex. A suicide and major depressive disorder (MDD), B alcohol use disorder and C early life adversity (ELA). SERT sites were labeled with [3H]-Cyanoimipramine. Note that: SERT is less in depressed suicide decedents and with MDD. With AUD there is more SERT but only in suicides, and there is more in ELA but only in nonsuicides. Values are expressed as mean ± SEM
Fig. 2 Serotonin transporter (SERT) binding in the prefrontal cortex. A suicide and major depressive disorder (MDD), B alcohol use disorder and C early life adversity (ELA). SERT sites were labeled with [3H]-Cyanoimipramine. Note that: SERT is less in depressed suicide decedents and with MDD. With AUD there is more SERT but only in suicides, and there is more in ELA but only in nonsuicides. Values are expressed as mean ± SEMCC BY · PubMed Central
Fig. 3 5-HT1A receptor binding in the prefrontal cortex. A suicide and major depressive disorder (MDD), B alcohol use disorder and C early life adversity (ELA). 5-HT1A receptors were labeled with [3H]-8-OH-DPAT. There is no data for BA8 or BA24 for MDD nonsuicides because there was only one case with these regions. Note: 5-HT1A binding was greater in suicides independent of MDD, AUD was associated with higher 5-HT1A binding but only in suicides, and ELA is associated with more 5-HT1A receptor binding. Values are expressed as mean ± SEM
Fig. 3 5-HT1A receptor binding in the prefrontal cortex. A suicide and major depressive disorder (MDD), B alcohol use disorder and C early life adversity (ELA). 5-HT1A receptors were labeled with [3H]-8-OH-DPAT. There is no data for BA8 or BA24 for MDD nonsuicides because there was only one case with these regions. Note: 5-HT1A binding was greater in suicides independent of MDD, AUD was associated with higher 5-HT1A binding but only in suicides, and ELA is associated with more 5-HT1A receptor binding. Values are expressed as mean ± SEMCC BY · PubMed Central
Fig. 4 5-HT2A receptor binding in the prefrontal cortex. A suicide and major depressive disorder (MDD), B alcohol use disorder and C early life adversity (ELA). 5-HT2A receptors were labeled with [3H]-Ketanserin. Note that: there is more 5-HT2A binding in suicides but no difference with MDD; there is more binding in AUD and ELA, but only in suicides. Values are expressed as mean ± SEM
Fig. 4 5-HT2A receptor binding in the prefrontal cortex. A suicide and major depressive disorder (MDD), B alcohol use disorder and C early life adversity (ELA). 5-HT2A receptors were labeled with [3H]-Ketanserin. Note that: there is more 5-HT2A binding in suicides but no difference with MDD; there is more binding in AUD and ELA, but only in suicides. Values are expressed as mean ± SEMCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 106 references

Research works printed but not linked: 3

  1. Labonte, B., Turecki, G. in The Neurobiological Basis of Suicide (ed Dwivedi, Y.) 275–296 (CRC Press, Boca Raton, 2012).
  2. Arango, V. & Mann, J. J. in Neurobiology of Mental Illness, 3rd edn (eds Charney, D. & Nestler E. J) 515–529 (Oxford University Press: Oxford, UK, 2009).
  3. Pandey, G. N. et al. in Contemporary Neuropsychiatry (eds Miyoshi, K., Shapiro, C. M., Gaviria M. & Morita Y) 314–321 (Springer-Verlag: Tokyo, 2001).

Cited by

See all 144

Metadata

Authors
Underwood, M. D., Kassir, S. A., Bakalian, M. J., Galfalvy, H., Dwork, A. J., Mann, J. J., & Arango, V.
Affiliations
  • Columbia University Irving Medical Center (US)
  • New York State Psychiatric Institute (US)
  • Macedonian Academy of Sciences and Arts (MK)
Corresponding author
Underwood, Mark D.
Venue
Translational Psychiatry
Published
2018-12-14
Volume
8
Issue
1
Pages
279-279
ISSN
2158-3188 (ISSN-L)
OpenAlex
W2904112223
Cited by
128
References
106
Citations by year
2026: 11 · 2025: 16 · 2024: 11 · 2023: 19 · 2022: 15 · 2021: 34 · 2020: 12 · 2019: 10
FWCI
6.37
Type
journal article
Language
en
Open access
Licence
Locations
  • Translational Psychiatry (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (MH40210, MH62185)
  • U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (AA09004, AA11293)
  • U.S. Department of Health & Human Services | National Institutes of Health (MH90964, MH64168)
  • Dr. Mann receives royalties for the commercial use of the C-SSRS from the Research Foundation for Mental Hygiene.
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Social Sciences › Psychology › Clinical Psychology › Suicide and Self-Harm Studies
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
Keywords
serotonin receptors, suicide, major depressive disorder, alcoholism, serotonin transporter, 5-HT1A receptor, 5-HT2A receptor, childhood adversity, prefrontal cortex, anterior cingulate cortex, psychological autopsy, sex differences
MeSH terms
Adverse Childhood Experiences, Adult, Alcoholism, Autoradiography, Brain, Major Depressive Disorder, Female, Gyrus Cinguli, Humans, Male, Middle Aged, Suicide, Prefrontal Cortex, Receptor, Serotonin, 5-HT1A, Receptor, Serotonin, 5-HT2A, Serotonin Plasma Membrane Transport Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity. https://app.cochat.ai/papers/10.1038/s41398-018-0309-1
The paper
Underwood, M. D., Kassir, S. A., Bakalian, M. J., Galfalvy, H., Dwork, A. J., Mann, J. J., & Arango, V. (2018). Serotonin receptors and suicide, major depression, alcohol use disorder and reported early life adversity. Translational Psychiatry. https://doi.org/10.1038/s41398-018-0309-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.